Osteoarthritis Trial, Recruiting NCT07309003 Sponsor: Ankara City Hospital Bilkent Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07309003
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 50 and 65 years old
  • People who have been diagnosed with primary knee osteoarthritis (wear-and-tear arthritis that originates in the knee itself, not caused by another condition) based on standard medical criteria
  • People whose knee osteoarthritis has been rated as moderate in severity (Grade 2 or 3 on a standard X-ray grading scale)
  • People who are able to follow and take part in an exercise program
  • People who agree to participate in the study

Who may not be able to join:

  • People who have a type of osteoarthritis that was caused by another underlying condition (called secondary osteoarthritis)
  • People who have had a significant knee injury, knee surgery, or an injection into the knee joint (such as a steroid or hyaluronic acid injection) within the last 6 months
  • People who currently have active inflammation inside the knee joint
  • People who have certain neurological conditions (such as Parkinson's disease, Alzheimer's disease, or nerve damage affecting multiple nerves), diabetes, inner ear/balance disorders, or any other condition that affects movement, pain levels, or the body's ability to sense joint position
  • People who have a heart or lung condition that means exercise would not be safe for them
  • People who have a history of a broken bone or surgery involving the leg, knee, or foot

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905393828686

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara City Hospital Bilkent
Registry
ClinicalTrials.gov
Start date
3 January 2025
Est. completion
30 December 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Quadriceps muscle strength; Visual Analog Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov